Intelligent Bio Solutions (INBS) Cash from Financing Activities (2020 - 2025)
Intelligent Bio Solutions (INBS) recorded quarterly Cash from Financing Activities of $3.3 million in Q1 2025, up 425.78% quarter-over-quarter from $631744.0 in Q4 2024, and down 69.16% on a YoY basis from $10.8 million in Q1 2024.
Intelligent Bio Solutions (INBS) Cash from Financing Activities (2020 - 2025) Analysis & Trends
Intelligent Bio Solutions' Cash from Financing Activities history runs 5 years deep, the most recent figure standing at $3.3 million for Q1 2025.
- In Q1 2025, Cash from Financing Activities fell 69.16% year-over-year to $3.3 million; the TTM figure through Mar 2025 stood at $14.8 million (up 17.81% YoY), while the FY2023 annual figure was $1.4 million, changed N/A from the prior year.
- Cash from Financing Activities was $3.3 million for Q1 2025 at Intelligent Bio Solutions, up from $631744.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $10.8 million in Q1 2024 to a low of $42450.0 in Q3 2024.
- Historically, Cash from Financing Activities has averaged $2.4 million across 4 years, with a median of $631744.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities soared 526.97% in 2024, then tumbled 69.16% in 2025.
- A 4-year view of Cash from Financing Activities shows it stood at $498100.0 in 2021, then plunged by 90.74% to $46110.0 in 2023, then surged by 1270.08% to $631744.0 in 2024, then surged by 425.78% to $3.3 million in 2025.
- The last three Cash from Financing Activities figures came in at $3.3 million (Q1 2025), $631744.0 (Q4 2024), and $42450.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -451.20 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 21.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -25.00 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Intelligent Bio Solutions | 12.72 Mn | 11.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 3.32 Mn |
| Mar 31, 2025 | 3.32 Mn |
| Dec 31, 2024 | 631,744.00 |
| Dec 31, 2024 | 631,744.00 |
| Sep 30, 2024 | 42,450.00 |
| Sep 30, 2024 | 42,450.00 |
| Mar 31, 2024 | 10.77 Mn |
| Mar 31, 2024 | 10.77 Mn |
| Jun 30, 2023 | 46,110.00 |
| Jun 30, 2023 | 46,110.00 |
| Mar 31, 2023 | 1.72 Mn |
| Mar 31, 2023 | 1.72 Mn |
| Mar 31, 2021 | 498,100.00 |
| Mar 31, 2021 | 498,100.00 |
| Dec 31, 2020 | 19.61 Mn |
| Dec 31, 2020 | 19.61 Mn |
| Sep 30, 2020 | 3.29 Mn |
| Sep 30, 2020 | 3.29 Mn |
| Jun 30, 2020 | 201,514.00 |
| Jun 30, 2020 | 201,514.00 |